Advanced Search

Amendment Determination under section 84AH of the National Health Act 1953 (2015) (No. 1) (PB 16 of 2015)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
PB 16 of 2015
Amendment Determination under section 84AH of the National Health Act 1953 (2015) (No. 1)
 
National Health Act 1953
___________________________________________________________________________
 
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this instrument under section 84AH of the National Health Act 1953.
Dated               24                February 2015
 
 
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
___________________________________________________________________
 
 
 
 
 
1              Name of Instrument
 
(1)                This Instrument is the Amendment Determination under section 84AH of the National Health Act 1953 (2015) (No. 1).
 
(2)                This Instrument may also be cited as PB 16 of 2015.
 
2              Commencement
                            This Instrument commences on 1 March 2015.
3              Amendments to PB 58 of 2007
                      Schedule 1 amends the legislative instrument titled Determination under section 84AH of the National Health Act 1953 (PB 58 of 2007) (as amended).
.
 
Schedule 1                   Amendments
 
      
 
[1]   Schedule 1, after entry for Erythromycin Powder for I.V.  infusion 1 g (as lactobionate), 50mL :
 
                        insert:
 
Escitalopram
Oral solution 20 mg (as oxalate) per mL, 15 mL
Oral
 
[2]   Schedule 1, after entry for Levodopa with Carbidopa Tablet 200 mg-50 mg (anhydrous) (modified release) :
 
                        insert:
 
Mercaptopurine
Oral suspension 20 mg per mL, 100 mL
Oral